Simplex Trading
ANRO icon

Simplex Trading’s Alto Neuroscience ANRO Stock Holding History

Simplex Trading’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111K Buy
+4,200
New +$97.1K ﹤0.01% 5423
2026
Q1 		– Sell
-9,000
Closed -$160K – 10366
2025
Q4 		$160K Buy
9,000
+1,200
+15% +$15.1K ﹤0.01% 4461
2025
Q3 		$31K Buy
7,800
+2,900
+59% +$9.62K ﹤0.01% 6949
2025
Q2 		$10K Sell
4,900
-2,200
-31% -$5.24K ﹤0.01% 7350
2025
Q1 		$15K Buy
7,100
+1,100
+18% +$3.94K ﹤0.01% 6814
2024
Q4 		$25K Buy
+6,000
New +$37.4K ﹤0.01% 6517

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Simplex Trading's ANRO Position: Q2 2026 in Review

Simplex Trading sold out of Alto Neuroscience (ANRO) in Q2 2026, closing a stake of 450 shares — an estimated $10.4K sold.

Simplex Trading first reported a position in ANRO in Q1 2025 and held it in 2 quarters. The position peaked at $10.1K in Q1 2026. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Simplex Trading reported no remaining Alto Neuroscience position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 450 Alto Neuroscience shares in Q2 2026, an estimated $10.4K.
  • Simplex Trading first reported a position in Alto Neuroscience in Q1 2025 and held it in 2 quarters.
  • Simplex Trading's Alto Neuroscience position peaked at $10.1K in Q1 2026.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.